| oshpd_id | manufacturer_name | date_reported | ndc_number | drug_product_description | wac_effective_date | wac_increase_amount | wac_after_increase | patent_expiration_date | drug_source_type | unit_sales_volume_in_us | unit_sales_volume_non_public_indicator | cost_increase_factors | cost_increase_factors_non_public_indicator | change_improvement_description | change_improvement_non_public_indicator | acquisition_date | company_acquired_from | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | wac_at_acquisition | wac_year_prior_to_acquisition | year_drug_introduced_to_market | wac_at_intro_to_market | supporting_documents | general_comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rx0000060 | Kyowa Kirin, Inc. | 03/31/2019 | 42747072601 | Sancuso (Granisetron Transdermal System) 3.1 mg/24 hrs 7-day patch | 02/12/2019 | 16.00 | 549.55 | 01/22/2025 | Single Source Drug | None | 1 | None | 1 | None | 1 | None | None | None | None | None | None | None | None | None | None | The NDC was not acquired within the last five years. |